Amide pyramidalization in carbamazepine: A flexibility problem in crystal structure prediction?

被引:60
作者
Cruz Cabeza, Aurora J.
Day, Graeme M.
Motherwell, W. D. Samuel
Jones, William
机构
[1] Univ Cambridge, Dept Chem, Pfizer Inst Pharmaceut Mat Sci, Cambridge CB2 1EW, England
[2] Cambridge Crystallog Data Ctr, Cambridge CB2 1EZ, England
关键词
D O I
10.1021/cg0601756
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Carbamazepine is known to exist in various polymorphic forms. Here we report on crystal structure prediction calculations for carbamazepine in an attempt to examine the predictability and relative stability of the various polymorphs. Hypothetical crystal structures generated in 10 of the most common space groups were compared to the observed polymorphs. Particular attention has been given to the influence of amide pyramidalization on the relative energies of the predicted structures. While the actual generation of possible crystal structures was found to be independent of the degree of deformation of the amide group, their final ranking in energy was greatly affected by pyramidalization of the amide nitrogen. This effect was examined in detail through systematic variation of the NH2 geometry for each of the low-energy crystal structures; different amide geometries were favored in the various low-energy crystal structures. The results demonstrate that energetically feasible deformation of the amide group may occur in order to optimize hydrogen-bond interactions, and we conclude that neglect of amide pyramidalization introduces significant errors in crystal structure prediction for carbamazepine and similar molecules.
引用
收藏
页码:1858 / 1866
页数:9
相关论文
共 50 条
  • [1] *ACC INC, 1997, CERIUS2 VER 4 6
  • [2] *ACC INC, 2004, MS MOD REL 3 0 1
  • [3] Correlation of the hydrogen-bond acceptor properties of nitrogen with the geometry of the Nsp(2)->Nsp(3) transition in R(1)(X=)C-NR(2)R(3) substructures: Reaction pathway for the protonation of nitrogen
    Allen, FH
    Bird, CM
    Rowland, RS
    Harris, SE
    Schwalbe, CH
    [J]. ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1995, 51 : 1068 - 1081
  • [4] AMOS RD, 1995, CADPAC VERSION 6 0
  • [5] X-RAY CRYSTALLOGRAPHIC CHARACTERIZATION OF 10,11-DIHYDRO-5H-DIBENZ[B,F]AZEPINE-5-CARBOXAMIDE
    BANDOLI, G
    NICOLINI, M
    ONGARO, A
    VOLPE, G
    RUBELLO, A
    [J]. JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH, 1992, 22 (02): : 177 - 183
  • [6] Ritonavir: An extraordinary example of conformational polymorphism
    Bauer, J
    Spanton, S
    Henry, R
    Quick, J
    Dziki, W
    Porter, W
    Morris, J
    [J]. PHARMACEUTICAL RESEARCH, 2001, 18 (06) : 859 - 866
  • [7] HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS
    BEHME, RJ
    BROOKE, D
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) : 986 - 990
  • [8] BERNSTEIN J, 2002, POLYM MOL CRYSTALS
  • [9] X-ray characterization of the triclinic polymorph of carbamazepine
    Ceolin, R
    Toscani, S
    Gardette, MF
    Agafonov, VN
    Dzyabchenko, AV
    Bachet, B
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) : 1062 - 1065
  • [10] Dealing with the impact of ritonavir polymorphs on the late stages of bulk drug process development
    Chemburkar, SR
    Bauer, J
    Deming, K
    Spiwek, H
    Patel, K
    Morris, J
    Henry, R
    Spanton, S
    Dziki, W
    Porter, W
    Quick, J
    Bauer, P
    Donaubauer, J
    Narayanan, BA
    Soldani, M
    Riley, D
    McFarland, K
    [J]. ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) : 413 - 417